Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 3

06:20 EDT 22nd October 2017 | BioPortfolio

Showing News Articles 51–75 of 113

Wednesday 16th November 2011

Alcoholics' 'injured brains' work harder to complete simple tasks: Finger tapping study shows alcoholics may recruit other brain regions

Alcoholic brains can perform a simple finger-tapping exercise as well as their sober counterparts but their brain must work a lot harder to do it, according to a new study.

Tuesday 15th November 2011

BioVista Inc. Graham Anthony ,working with pharma companies to help them get best out of their own drugs

In this episode of PharmaTelevision News Review, Fintan Walton talks to Graham Anthouny, CFO of BioVista Inc.

European Biotechnology Network: Claire Skentelbery explains why partnerships are now the key thing to deliver technologies

In this episode of PharmaTelevision News Review, Paul Larsmon talks to Claire Skentelbery, Secretary General of European Biotechnology Network.

GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes

Head-to-head study primary end point did not meet non-inferiority, but results support progression towards registration

Mental illness: Early-life depression and anxiety changes structure of developing brain

New research identifies the brain chemicals and circuits involved in mental illnesses like schizophrenia, depression, and anxiety, giving potential new directions to their treatment. In addition, research with children shows that early-life depression and anxiety changes the structure of the developing brain.

Everybody can become a better a reader, Swedish research suggests

Students with cognitive impairments may learn to comprehend written texts much better than commonly thought, according to researchers in Sweden.

Watching less TV, being more active and sleeping more is linked to a healthy body weight in young children

Getting enough sleep can help children maintain a healthy weight, new research reveals. Similarly, the more time children spend in front of the TV or their computers (screen time), the higher their body weight.

Serotonin system in women's brains is damaged more readily by alcohol than that in men’s brains, study finds

After only four years of problem drinking, a significant decrease in the function of the serotonin system in women’s brains can be seen. This is the system that regulates such functions as impulse control and mood. It takes 12 years before a corresponding decrease is seen in men.

Gene impedes recovery from alcoholism, Swedish research finds

People who are alcohol-dependent and who also carry a particular variant of a gene run an increased risk of premature death, according to research from Sweden.

Healthcare of transsexual persons causes unnecessary suffering, Swedish study finds

In 1972, Sweden became the first country in the world to legislate healthcare for transsexualism within the state-financed healthcare system. In an international perspective, this was considered to be radical. It was expected that the life situation of people in the transsexual group would improve, now that state-financed healthcare was available for this group. New research from Sweden, however, ...

How the brain perceives shades of gray

Groundbreaking research provides new insight into how the brain perceives color.

Mimicking the brain -- in silicon: New computer chip models how neurons communicate with each other at synapses

For decades, scientists have dreamed of building computer systems that could replicate the human brain's talent for learning new tasks. Researchers have now taken a major step toward that goal by designing a computer chip that mimics how the brain's neurons adapt in response to new information. This phenomenon, known as plasticity, is believed to underlie many brain functions, including learning a...

Midatech receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles

Oxford, UK, 15 November 2011 – Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG. The trial is designed to assess the safety profile...

Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting.

Revascor™, Mesoblast’s proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells Revascor™ therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive heart failure over a mean follow-up o...

Mesoblast to Host Conference Call to Discuss RevascorTM Data Presented at American Heart Association

Melbourne, Australia; 15 November 2011: Global regenerative medicine company, Mesoblast Limited (ASX: MSB; OTC ADR: MBLTY), will host an investor conference call and webcast on Tuesday 15 November 8:15am Australian EDT (Monday, 14 November 2011 at 4:15pm U.S. EST, 9:15pm UK) following the presentation of data from its congestive heart failure clinical trial from 9:15am to 9:25am U.S. EST at t...

Monday 14th November 2011

High childhood IQ linked to subsequent illicit drug use, research suggests

A high childhood IQ may be linked to subsequent illegal drug use, particularly among women, new research suggests.

Telephone-based therapy and exercise appear effective for reducing chronic widespread pain

Telephone-delivered cognitive behavioral therapy and an exercise program, both separately and combined, are associated with short-term positive outcomes for patients with chronic widespread pain, and may offer benefits for patients diagnosed with fibromyalgia, according to a new report.

GE Healthcare expands Biacore™ histidine capture portfolio with launch of His Capture Kit and NTA Reagent Kit

November 14 2011: GE Healthcare has launched the His Capture Kit and NTA Reagent Kit for time saving and convenient capture of histidine-tagged ligands using Biacore systems. The new His Capture Kit comprises of an optimized protocol and the required reagents for capture by an anti-histidine antibody. Requiring minimum assay development, the kit works in conjunction with a carboxyl-derivatize...

Skeletal Biology and Medicine I

This Annals volume presents manuscripts stemming from the 4th New York Skeletal Biology and Medicine Conference, held at Mount Sinai School of Medicine in New York City on April 27–30, 2011.Volume 1237

Thursday 10th November 2011

2011 Scrip Awards

Novartis received three 2011 Scrip Awards: Pharma Company of the Year, Best New Drug and Executive of the Year.

North West Fund for Biomedical invest £100K in University-spin out and healthcare sensor firms

10 November 2011: The University of Salford’s first ever drug development spin-out company Onco-NX and Manchester-based Kanichi Research Services Ltd have secured investment from the North West Fund for Biomedical. Drug discovery spin-out company Onco-NX and Kanichi Research Services, which develops a bespoke range of sensors for the healthcare market, have each received £5...

Verona Pharma - Phase IIa RPL554 Study Reports Positively for Safety and Bronchodilation in Patients with Mild to Moderate COPD

10 November 2011 - London, UK - Verona Pharma plc (AIM: VRP.L), the biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, has successfully demonstrated in a Phase IIa RPL554 study bronchodilator effects in patients with chronic obstructive pulmonary disease (“COPD”). The pilot Phase IIa study was carried out by a world leadi...

Mesoblast Reports Positive Results Using Intravenously Injected Adult Stem Cells for Type 2 Diabetes.

Key Points Single injection of Mesoblast's proprietary allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) significantly lowered blood sugar levels for up to eight weeks in non-human primates with Type 2 diabetes A clear dose-dependent effect was seen, with the highest three MPC doses maintaining significantly reduced blood glucose levels after eight weeks compared w...

Driving diffraction’s dry powder dispersion - New Mastersizer 3000 measures the particle size of even friable dry powders

10 November 2011: Malvern, UK: Equipped with the novel Aero dry dispersion unit, the new Mastersizer 3000 particle size analyzer from Malvern Instruments now extends dry measurement to the widest possible range of sample types. The design of the Aero reflects state-of-the-art dry powder dispersion knowledge and enables users to measure materials from cement to coffee, cohesive minerals to fra...

Wednesday 9th November 2011

Alcohol and Breast Cancer Risk

Studies have consistently shown a “linear dose-response” relationship between alcohol intake and breast cancer risk in women. This basically means that the more alcohol you consume on a daily basis the higher your lifetime risk of breast cancer. The exact mechanism by which alcohol leads to an increased risk of breast cancer is unknown however [...]Related Posts:


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.